Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in XGN — Exagen Inc.

CIK 19617 NEW YORK, NY
Back to XGN Full portfolio

Position in XGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$594
+$579 QoQ
Shares Held
128
+2460.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 57 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $14,851,050,368 across 35 Diagnostics & Research names. XGN ranks #34 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 8,503,527 $4,263,328,287
2 NTRA
Natera, Inc.
 12,865,346 $3,492,298,164
3 DHR
Danaher Corp /De/
 12,185,400 $2,321,074,982
4 IQV
Iqvia Holdings Inc.
 6,139,775 $1,186,327,314
5 WAT
Waters Corp /De/
 2,158,391 $809,482,952
6 DGX
Quest Diagnostics Inc
 3,520,438 $746,156,824
7 IDXX
Idexx Laboratories Inc /De
 755,791 $397,878,607
8 LH
Labcorp Holdings Inc.
 1,268,384 $355,147,520

All Filings in XGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $594 128
2026-03-31 $15 5
2025-12-31 $23,742 3,905
2025-09-30 $176,047 16,019
2025-06-30 $34 5
2025-03-31 $17 5
2024-12-31 $20 5
2024-09-30 $107 35
2024-06-30 $63 35
2024-03-31 $53 34
2023-12-31 $48 25
2023-09-30 $5,510 2,277
2023-06-30 $6,562 2,263
2023-03-31 $5,498 2,263
2022-12-31 $5,620 2,342
2022-09-30 $14,706 5,427
2022-06-30 $45,207 7,876
2022-03-31 $71,458 8,899
2021-12-31 $245,776 21,133
2021-09-30 $211,289 15,536
2021-06-30 $282,455 18,843
2021-03-31 $250,179 14,296
2020-12-31 $180,694 13,689
2020-09-30 $52,378 4,832
2020-06-30 $70,103 5,649
2020-03-31 $133,209 8,357